Featured Research

from universities, journals, and other organizations

Mayo Clinic Researchers Discover Enzyme Has Potential To Stop Multiple Sclerosis Tissue Damage

Date:
May 24, 2002
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers have found a new clue in the search for a way to stop the tissue damage, or demyelination, that occurs in multiple sclerosis (MS) or related central nervous system diseases. They found a dramatic increase in a newly discovered degradative enzyme, myelencephalon-specific protease (MSP), in demyelinated tissue, indicating that inhibiting this enzyme could potentially block the process of tissue damage.

ROCHESTER, MINN. -- Mayo Clinic researchers have found a new clue in the search for a way to stop the tissue damage, or demyelination, that occurs in multiple sclerosis (MS) or related central nervous system diseases. They found a dramatic increase in a newly discovered degradative enzyme, myelencephalon-specific protease (MSP), in demyelinated tissue, indicating that inhibiting this enzyme could potentially block the process of tissue damage.

Related Articles


This is a first-ever finding of the link between MSP and the debilitation that patients experience in MS.

This study will be published in the June 2002 issue of Brain, published by Oxford University Press, http://brain.oupjournals.org/.

"If you could control this enzyme, you could possibly decrease the development of disease," said Isobel Scarisbrick, Ph.D., Mayo Clinic neuroscientist and lead author of this study. "Excess MSP, as is present in inflammatory central nervous system lesions such as those in MS, may promote demyelination."

Dr. Scarisbrick and colleagues discovered MSP in 1997 while she was a research fellow at Mayo Clinic in Jacksonville, Fla. They cloned MSP and developed probes and other tools to work with the enzyme and attempt to determine its role in demyelination.

In the researchers' investigation of mouse and human MS tissue, they discovered MSP's dramatic increase in inflammatory cells in actively demyelinating human MS lesions. MSP is a multifunctional enzyme, facilitating entry of inflammatory cells into the brain and also contributing to tissue destruction when overexpressed. It also may harm processes of the oligodendroglia, cells found in the central nervous system that form the myelin sheath protecting the axon, a component of nerve cells. When functioning normally, however, MSP contributes to proper oligodendroglia function.

In the MS field, researchers have made many strides in learning about the genetics, origin and development of the disease, but no treatment has yet been found to be effective in treating all MS cases. Dr. Scarisbrick and colleagues view their new findings cautiously and not as a panacea, but yet are hopeful about the possibilities for future treatment development.

"We're not reporting this as a cure, but it represents something that could be targeted for therapy," says Dr. Scarisbrick. "We have a lot more work to do." Her colleague, Moses Rodriguez, M.D., Mayo Clinic neurologist, concurs. "This is a very important enzyme," says Dr. Rodriguez. "It really has therapeutic potential."

This study was supported by a pilot study grant from the National Multiple Sclerosis Society.

MS is an inflammatory demyelinating central nervous system (CNS) disease. It occurs most commonly in those between the ages of 20 and 40, and it is the most frequent neurological disorder in young adults in North America and Europe. Approximately 330,000 people in the United States have MS. Though researchers are still investigating the precise causes of MS and related CNS diseases, it is thought to be an autoimmune disease resulting from a triggering of the body's own immune system to destroy the myelin sheath covering the nerve fibers.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Researchers Discover Enzyme Has Potential To Stop Multiple Sclerosis Tissue Damage." ScienceDaily. ScienceDaily, 24 May 2002. <www.sciencedaily.com/releases/2002/05/020524072313.htm>.
Mayo Clinic. (2002, May 24). Mayo Clinic Researchers Discover Enzyme Has Potential To Stop Multiple Sclerosis Tissue Damage. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2002/05/020524072313.htm
Mayo Clinic. "Mayo Clinic Researchers Discover Enzyme Has Potential To Stop Multiple Sclerosis Tissue Damage." ScienceDaily. www.sciencedaily.com/releases/2002/05/020524072313.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins